M
Minna Tervahartiala
Researcher at University of Turku
Publications - 4
Citations - 46
Minna Tervahartiala is an academic researcher from University of Turku. The author has contributed to research in topics: Bladder cancer & Cancer. The author has an hindex of 2, co-authored 4 publications receiving 27 citations.
Papers
More filters
Journal ArticleDOI
Cell-type-specific CD73 expression is an independent prognostic factor in bladder cancer.
Maarit K Koivisto,Minna Tervahartiala,Istvan Kenessey,Sirpa Jalkanen,Peter J. Boström,Marko Salmi +5 more
TL;DR: It is concluded that in contrast to many other cancer types, high CD73 expression in BC predicts favorable prognosis.
Journal ArticleDOI
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer.
Minna Tervahartiala,Pekka Taimen,Tuomas Mirtti,Ilmari Koskinen,Thorsten H. Ecke,Sirpa Jalkanen,Peter J. Boström +6 more
TL;DR: It is pointed out that CD68, MAC387, and CLEVER-1 may be useful prognostic and predictive markers in BC and in response to NAC and outcome of BC.
Journal ArticleDOI
Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy.
Thorsten H. Ecke,Adisch Kiani,Thorsten Schlomm,Frank Friedersdorff,Anja Rabien,Klaus Jung,Ergin Kilic,Peter J. Boström,Minna Tervahartiala,Pekka Taimen,Jan Gleichenhagen,Georg Johnen,Thomas Brüning,Stefan Koch,Jenny Roggisch,Ralph M. Wirtz +15 more
TL;DR: For muscle-invasive bladder cancer patients, the proliferative activity as determined by the nuclear staining of survivin or RT-qPCR on the basis of molecular subtype characteristics outperforms single marker detections and single technology approaches.
Journal ArticleDOI
Prediction of neo-adjuvant chemotherapy response in bladder cancer: the impact of clinical parameters and routine biomarkers
Ilmari Koskinen,Peter J. Boström,Pekka Taimen,Pekka Taimen,Antti Salminen,Minna Tervahartiala,Jukka Sairanen,Andrew Erickson,Andrew Erickson,Tuomas Mirtti +9 more
TL;DR: In this article, the role of clinical parameters and immunohistochemical (IHC) biomarkers in their feasibility to predict the effect of neo-adjuvant chemotherapy (NAC) in patients with muscle-invasive urothelial bladder cancer (MIBC).